抗体薬物複合体（ADC）の世界市場

The Business Research Company（TBRC）「抗体薬物複合体（ADC）の世界市場：2033年までの市場機会と戦略 – Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033」は世界の抗体薬物複合体（ADC）市場を調査し、主要セグメント毎に分析・予測を行っています。

主な調査対象セグメント

• リンカータイプ
  • 切断型リンカー
  • 非切断型リンカー
• 製品タイプ
  • Kadcyla
  • エンハーツ
  • アドセトリス
  • ポライビー
  • Trodelvy
  • PADCEV
• 用途タイプ
  • 造血器悪性腫瘍
  • 乳がん
  • 卵巣がん
  • 肺がん
  • 脳腫瘍
• エンドユーザタイプ
  • 病院
  • クリニック
  • 専門センター

調査対象企業

• F. Hoffmann-La Roche Ltd.
• 第一三共株式会社
• Seagen Inc.
• Gilead Sciences Inc.
• Genmab

Report Description

Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global antibody drug conjugates market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest-growing market for antibody drug conjugates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The antibody drug conjugates market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider antibody drug conjugates market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by linker type, by product, by application and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the antibody drug conjugates market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by linker type, by product, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for antibody drug conjugates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:
1) By Linker Type: Cleavable Linker; Non-Cleavable Linker
2) By Product: Kadcyla; Enhertu; Adcetris; Polivy; Trodelvy; Padcev; Other Products
3) By Application: Hematopoietic Cancers; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Other Applications
4) By End User: Hospital; Clinics; Specialty Centers; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; antibody drug conjugates indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table Of Contents

1 Executive Summary
1.1 Antibody Drug Conjugates – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Antibody Drug Conjugates Market Definition And Segmentations
6.4 Market Segmentation By Linked Type
6.4.1 Cleavable Linker
6.4.2 Non-cleavable Linker
6.5 Market Segmentation By Product
6.5.1 Adcetris
6.5.2 Kadcyla
6.5.3 Enhertu
6.5.4 Polivy
6.5.5 Trodelvy
6.5.6 Padcev
6.5.7 Other Products
6.6 Market Segmentation By Application
6.6.1 Hematopoietic Cancers
6.6.2 Breast Cancer
6.6.3 Lung Cancer
6.6.4 Brain Tumor
6.6.5 Ovarian Cancer
6.6.6 Other Applications
6.7 Market Segmentation By End User
6.7.1 Hospitals And Clinics
6.7.2 Specialty Centers
6.7.3 Other End-Users
7 Major Market Trends
7.1 Strategic Partnerships And Collaborations Among Market Players
7.2 Significant Investments In R&D By Market Players
7.3 Focus On New mAb Targets For ADCs Development
8 Antibody Drug Conjugates Market – Macro Economic Scenario
8.1 COVID-19 Impact On The Antibody Drug Conjugates Market
8.2 Impact Of The War In Ukraine On The Antibody Drug Conjugates Market
8.3 Impact Of High Inflation On The Antibody Drug Conjugates Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
9.2.1 Market Drivers 2018 – 2023
9.2.2 Market Restraints 2018 – 2023
9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023 – 2028
9.3.2 Market Restraints 2023 – 2028
10 Global Antibody Drug Conjugates Market Segmentation
10.1 Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11 Antibody Drug Conjugates Market, Regional and Country Analysis
11.1 Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Antibody Drug Conjugates Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
12.9.1 Country Information
12.9.2 Market Information
12.9.3 Background Information
12.9.4 Government Initiatives
12.9.5 Regulations
12.9.6 Regulatory Bodies
12.9.7 Major Associations
12.9.8 Taxes Levied
12.9.9 Corporate Tax Structure
12.9.10 Investments
12.9.11 Major Companies
12.10 China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.11 China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.12 China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.15 India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.16 India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Antibody Drug Conjugates Market: Country Analysis
13.7 UK Market
13.8 UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.17 France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.18 France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Antibody Drug Conjugates Market: Country Analysis
14.7 Russia Market
14.8 Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Antibody Drug Conjugates Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.10 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Major Companies
16.3 South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Antibody Drug Conjugates Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Major Companies
18.3 Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.1 F. Hoffman-La Roche Ltd
19.1.1 Company Overview
19.1.2 Products And Services
19.1.3 Business Strategy
19.1.4 Financial Overview
19.2 Daiichi Sankyo Company Limited
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Seagen Inc
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Gilead Sciences Inc
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Genmab A/S
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
20 Other Major And Innovative Companies
20.1 Pfizer
20.1.1 Company Overview
20.1.2 Products And Services
20.2 GlaxoSmithKline plc
20.2.1 Company Overview
20.2.2 Products And Services
20.3 ADC Therapeutics SA
20.3.1 Company Overview
20.3.2 Products And Services
20.4 AstraZeneca plc
20.4.1 Company Overview
20.4.2 Products And Services
20.5 RemeGen
20.5.1 Company Overview
20.5.2 Products And Services
20.6 Astellas Pharma Inc.
20.6.1 Company Overview
20.6.2 Products And Services
20.7 ImmunoGen Inc.
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Rakuten Medical
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Takeda Pharmaceutical Company Limited
20.9.1 Company Overview
20.9.2 Products And Services
20.10 AbbVie Inc.
20.10.1 Company Overview
20.10.2 Products And Services
20.11 Mersana Therapeutics Inc.
20.11.1 Company Overview
20.11.2 Products And Services
20.12 Merck Co. & KGaA
20.12.1 Company Overview
20.12.2 Products And Services
20.13 Bristol Myers Squibb Co.
20.13.1 Company Overview
20.13.2 Products And Services
20.14 Novo Nordisk A/S
20.14.1 Company Overview
20.14.2 Products And Services
20.15 Bayer AG
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Genmab A/S Acquired ProfoundBio Inc
23.2 Johnson & Johnson (J&J) Acquired Ambrx Biopharma Inc
23.3 AbbVie Acquired ImmunoGen, Inc
23.4 Pfizer Inc Acquired Seagen Inc
24 Opportunities And Strategies
24.1 Global Antibody Drug Conjugates Market In 2028 – Countries Offering Most New Opportunities
24.2 Global Antibody Drug Conjugates Market In 2028 – Segments Offering Most New Opportunities
24.3 Global Antibody Drug Conjugates Market In 2028 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Antibody Drug Conjugates Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
Table 2: Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
Table 3: Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 4: Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 5: Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 6: Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 7: Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 8: Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 9: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
Table 10: Asia-Pacific Population, By Country, 2018-2028, Millions
Table 11: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 12: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 13: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 14: China GDP Per Capita, 2018-2023, $
Table 15: China Population, 2018-2028, Millions
Table 16: China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 17: China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 18: China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 19: India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 20: India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 21: India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 22: Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 23: Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 24: Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 25: Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 26: Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 27: Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 28: Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 29: Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 30: Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 31: South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 32: South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 33: South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 34: Western Europe GDP Per Capita, By Country, 2018-2023, $
Table 35: Western Europe Population, By Country, 2018-2028, Millions
Table 36: Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 37: Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 38: Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 39: UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 40: UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 41: UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 42: Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 43: Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 44: Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 45: France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 46: France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 47: France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 48: Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 49: Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 50: Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 51: Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 52: Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 53: Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 54: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 55: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 56: Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 57: Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 58: Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 59: Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 60: Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 61: Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 62: North America GDP Per Capita, By Country, 2018-2023, $
Table 63: North America Population, By Country, 2018-2028, Millions
Table 64: North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 65: North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 66: North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 67: USA GDP Per Capita, 2018-2023, $
Table 68: USA Population, 2018-2028, Millions
Table 69: USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 70: USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 71: USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 72: Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 73: Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 74: Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 75: South America GDP Per Capita, By Country, 2017-2022, $
Table 76: South America Population, By Country, 2017-2027, Millions
Table 77: South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 78: South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 79: South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 80: Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 81: Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 82: Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 83: Middle East GDP Per Capita, By Country, 2018-2023, $
Table 84: Middle East Population, By Country, 2018-2028, Millions
Table 85: Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 86: Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 87: Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 88: Africa GDP Per Capita, By Country, 2018-2023, $
Table 89: Africa Population, By Country, 2018-2028, Millions
Table 90: Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 91: Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 92: Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 93: Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Table 94: F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
Table 95: Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
Table 96: Seagen Inc – Financial Overview, 2022, $Billion
Table 97: Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
Table 98: Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
Table 99: Antibody Drug Conjugates Market, Competitive Benchmarking (In USD Millions)
Table 100: Antibody Drug Conjugates Market, Competitive Dashboard
Table 101: Global Antibody Drug Conjugates Market Size Gain ($ Million), 2023 – 2028, By Country
Table 102: Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Linker Type, 2023 – 2028
Table 103: Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028
Table 104: Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By End User, 2023 – 2028
Table 105: Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Product, 2023 – 2028
Table 106: Antibody Drug Conjugates Market Data Sources

List Of Figures

Figure 1: Global Antibody Drug Conjugates Market Segmentation By Linked Type
Figure 2: Global Antibody Drug Conjugates Market Segmentation By Product
Figure 3: Global Antibody Drug Conjugates Market Segmentation By Product
Figure 4: Global Antibody Drug Conjugates Market Segmentation By End User
Figure 5: Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
Figure 6: Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
Figure 7: Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 8: Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 9: Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 10: Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 11: Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 12: Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 13: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 14: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 15: Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 16: China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 17: China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 18: China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 19: India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 20: India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 21: India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 22: Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 23: Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 24: Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 25: Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 26: Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 27: Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 28: Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 29: Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 30: Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 31: South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 32: South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 33: South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 34: Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 35: Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 36: Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 37: UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 38: UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 39: UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 40: Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 41: Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 42: Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 43: France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 44: France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 45: France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 46: Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 47: Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 48: Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 49: Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 50: Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 51: Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 52: Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 53: Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 54: Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 55: Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 56: Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 57: Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 58: North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 59: North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 60: North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 61: USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 62: USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 63: USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 64: Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 65: Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 66: Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 67: South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 68: South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 69: South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 70: Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 71: Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 72: Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 73: Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 74: Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 75: Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 76: Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 77: Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 78: Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 79: Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Figure 80: F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
Figure 81: Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
Figure 82: Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
Figure 83: Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
Figure 84: Geographic Regions Covered

The Business Research Company（ザ・ビジネスリサーチカンパニー／TBRC）は二次調査、専門家へのインタビュー、自社データ、アナリストの知見などを基に市場戦略を決定する上で必要な情報を市場調査レポートやカスタム調査を通じて提供しています。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
パターン1

パターン2

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス (Individual License)
    • 提供ファイル：PDF＋Excel
    • 1名のみレポートファイルのご利用が可能です。
  • サイトライセンス
    • 提供ファイル：PDF＋Excel
    • 同一企業および同一住所内人数無制限でレポートファイルのご共有が可能です
  • エンタープライズライセンス
    • 提供ファイル：PDF＋Excel
    • 同一企業およびグループ企業間人数無制限でレポートファイルのご共有が可能です
• 納品方法
  • Eメール
• 納期
  • 市場機会と戦略シリーズ（Global Market Opportunities And Strategies）：ご注文後2営業日以内
  • 世界市場レポートシリーズ（Global Market Report）：ご注文後5-7営業日前後

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

The Business Research Company（ザ・ビジネスリサーチカンパニー／TBRC）医療・通信・製造業など27の産業に精通した28ヶ国・350名以上の専任アナリストがThe Business Research Companyに所属し、カスタム調査および市場調査レポートの出版を積極的に行っています。

株式会社SEMABIZはThe Business Research Companyの日本の販売代理店として、レポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。

最新調査レポート

• 宇宙交通管理の世界市場
• 農業・建設・鉱山機械の世界市場
• MICE（会議、インセンティブ、カンファレンス、展示会）の世界市場
• 電動キックスクーターの世界市場
• 地雷探知システムの世界市場

The Business Research Company  出版レポート一覧